# Efficacy and Safety Study of Thioctacid Oral Tablets 600mg to Treat Chinese Diabetic Patients With Distal Symmetric Polyneuropathy

> **NCT01224353** · PHASE2,PHASE3 · UNKNOWN · sponsor: **NovaMed Pharmaceuticals Inc.** · enrollment: 200 (estimated)

## Conditions studied

- Diabetics

## Interventions

- **DRUG:** lipoic acid
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT01224353
- **Lead sponsor:** NovaMed Pharmaceuticals Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-11
- **Primary completion:** 2011-05
- **Final completion:** 2011-07
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2010-10-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01224353

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01224353, "Efficacy and Safety Study of Thioctacid Oral Tablets 600mg to Treat Chinese Diabetic Patients With Distal Symmetric Polyneuropathy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01224353. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*